Drug
Biocon Insulin R
Biocon Insulin R: highest development phase Phase 1, developed by Biocon. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| Biocon Insulin R NCT04022317 | Phase 1 | Healthy Volunteer |
Latest
No recent events.
Follow Biocon Insulin R on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.